Here's how NCBI.NLM.NIH.GOV makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NCBI . NLM . NIH . GOV {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Ncbi.nlm.nih.gov Make Money
  6. Keywords
  7. Topics
  8. Social Networks
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. Hosting Providers
  13. CDN Services

We began analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC9012680/, but it redirected us to https://pmc.ncbi.nlm.nih.gov/articles/PMC9012680/. The analysis below is for the second page.

Title[redir]:
Phase I/II trial of enzalutamide and mifepristone, a glucocorticoid receptor antagonist, for metastatic castration-resistant prostate cancer - PMC
Description:
Although androgen deprivation therapy (ADT) and androgen receptor signaling inhibitors (ARSI) are effective in metastatic prostate cancer (PC), resistance occurs in most patients. This phase I/II trial assessed the safety, pharmacokinetic impact, ...

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 6,694,437 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

We're unsure if the website is profiting.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Ncbi.nlm.nih.gov has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

enz, mif, patients, cancer, psa, phase, study, google, scholar, prostate, doi, pubmed, dose, receptor, progression, pmc, enzmif, androgen, free, week, article, enzalutamide, clinical, combination, ctcs, arm, trial, randomization, time, weeks, expression, crpc, day, pfs, figure, glucocorticoid, randomized, levels, group, therapy, grade, analysis, mifepristone, daily, ctc, dosing, resistance, survival, studies, combined,

Topics {✒️}

abdominal/pelvic cross-sectional imaging neo-adjuvant castrate-sensitive stage castration-sensitive prostate cancer castration-resistant prostate cancer high-throughput florescence microscopy median progression-free survival enz-mif drug-drug interactions androgen-independent prostate cancer castrate-resistant prostate cancer pre-planned dose combinations line castration-sensitive setting pmc beta search androgen-receptor signaling axis ligand-independent ar activation pre-operative setting demonstrated study-drug-attributable grade 4 previous placebo-controlled trials cell-line cells spiked nuclear hormone activity long-term gr blockade absolute 5ng/ml increase dual ar-gr antagonism pre-randomization psa rr planned psa-progression events activate lbd-mutant ar advanced prostate cancer key secondary endpoints metastatic prostate cancer average post-randomization testosterone acknowledgements funding glucocorticoid receptor antagonist post-randomization time point castration-resistant pc prostate specific antigen phase ii endpoints defense cdmrp w81xwh-14-1-0021 androgen receptor blockade post-randomization analysis due adrenocorticotropic hormone leading trough drug concentration post-treatment psa increase human prostate cancer combination ar/gr inhibition glucocorticoid/progesterone antagonist [google scholar] 31 [google scholar] 34 [google scholar] 35 [google scholar] 36 [google scholar] 49 mol cancer ther

External Links {🔗}(110)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Analytics 4
  • Google Tag Manager

Libraries {📚}

  • Foundation
  • jQuery
  • jQuery module (jquery-3.6.0)
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • nihcesxway.hub.nih.gov
  • nihcesxway2.hub.nih.gov
  • nihcesxway3.hub.nih.gov
  • nihcesxway4.hub.nih.gov
  • nihcesxway5.hub.nih.gov

Name Servers:

  • dns1-ncbi.ncbi.nlm.nih.gov
  • dns2-ncbi.ncbi.nlm.nih.gov
  • lhcns1.nlm.nih.gov
  • lhcns2.nlm.nih.gov

CDN Services {📦}

  • Ncbi

3.69s.